Hyperlipidaemia and Neutrophil count increased

Summary:

Neutrophil count increased is found among people with Hyperlipidaemia, especially for people who are male, 60+ old.

The study analyzes which people have Neutrophil count increased with Hyperlipidaemia. It is created by eHealthMe based on reports of 84 people who have Hyperlipidaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,426 drugs and 1,408 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

What is Neutrophil count increased?

Neutrophil count increased (excess than normal number of neutrophil a type of blood cell) is found to be associated with 942 drugs and 1,168 conditions by eHealthMe. Check the latest studies of Neutrophil count increased.



On Jul, 29, 2026

84 people who have Hyperlipidaemia and Neutrophil Count Increased are studied.

Would you have Neutrophil count increased when you have Hyperlipidaemia?

Gender of people who have Hyperlipidaemia and experienced Neutrophil Count Increased *:

  • female: 41.98 %
  • male: 58.02 %

Age of people who have Hyperlipidaemia and experienced Neutrophil Count Increased *:

  • 0-1: 0.0 %
  • 2-9: 1.32 %
  • 10-19: 0.0 %
  • 20-29: 3.95 %
  • 30-39: 5.26 %
  • 40-49: 10.53 %
  • 50-59: 19.74 %
  • 60+: 59.21 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 34 people, 40.48%
  2. Diabetes: 17 people, 20.24%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 16.67%
  4. Depression: 13 people, 15.48%
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 11 people, 13.10%
  6. High Blood Cholesterol: 8 people, 9.52%
  7. Osteoporosis (bones weak and more likely to break): 7 people, 8.33%
  8. Malignant Melanoma (skin cancer rises from melancytes): 7 people, 8.33%
  9. Haemorrhage (bleeding): 6 people, 7.14%
  10. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 6 people, 7.14%

Common drugs taken by these people *:

  1. Lipitor: 34 people, 40.48%
  2. Norvasc: 14 people, 16.67%
  3. Aspirin: 12 people, 14.29%
  4. Crestor: 9 people, 10.71%
  5. Clozaril: 8 people, 9.52%
  6. Amaryl: 7 people, 8.33%
  7. Diovan: 6 people, 7.14%
  8. Simvastatin: 6 people, 7.14%
  9. Zosyn: 6 people, 7.14%
  10. Amlodipine: 6 people, 7.14%

Common symptoms for these people *:

  1. White Blood Cell Count Increased: 51 people, 60.71%
  2. Lymphocyte Count Decreased: 26 people, 30.95%
  3. Fever: 26 people, 30.95%
  4. Blood Creatinine Increased: 24 people, 28.57%
  5. Blood Glucose Increased: 23 people, 27.38%
  6. Thrombocytopenia (decrease of platelets in blood): 21 people, 25.00%
  7. Haemoglobin Decreased: 20 people, 23.81%
  8. Dyspnea (difficult or laboured breathing): 19 people, 22.62%
  9. Acute Kidney Failure: 18 people, 21.43%
  10. High Blood Cholesterol: 16 people, 19.05%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Neutrophil count increased?

- Check whether Neutrophil count increased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Neutrophil count increased:

All the conditions that are associated with Neutrophil count increased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Neutrophil count increased and Hyperlipidaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: